Dáil Éireann Debate, Wednesday - 24 January 2024
215. Deputy Catherine Connolly asked the Minister for Health for an update regarding the appointment of an independent chairperson to the sodium valproate inquiry; when he expects the chairperson to be appointed; and if he will make a statement on the matter. [3302/24]
View answer216. Deputy Catherine Connolly asked the Minister for Health the status of the inquiry into the historical licencing and prescribing of sodium valproate; the timeline for the inquiry; and if he will make a statement on the matter. [3303/24]
View answerI propose to take Questions Nos. 215 and 216 together.
Government approval has been secured for the establishment of an inquiry which will examine the licensing and use of sodium valproate in women of child-bearing potential in the State. This inquiry will be designed to give a voice to patients and their families while looking at the use of sodium valproate in Ireland since it was first licensed.
There is more work to be done to establish the inquiry and it is important that enough time and resources are invested in completing this work. There are many factors to consider, and I want to ensure that the inquiry established delivers and allows those impacted to tell their story and my officials are working to ensure that this will be facilitated. My officials are engaging with the relevant patient groups.
It is my intention to ensure the establishment of the inquiry is progressed. Work is actively ongoing in my Department in relation to sourcing an appropriate person to Chair the inquiry, and the Deputy will appreciate that this is a sensitive matter. The Chair is an essential role that needs careful consideration. The role requires and experienced person who will run a fair and independent process, and who can give the inquiry the time and attention it deserves.
I will be glad to provide an update on this matter once this work is finalised.
